IMMUNOTHERAPY: Cancer vaccine triggers antiviral-type defences


    loading  Checking for direct PDF access through Ovid

Abstract

An immunotherapy approach targets nanoparticles to dendritic cells of the immune system, leading to an antitumour immune response with antiviral-like features. Initial clinical tests of this approach show promise. See Letter p.396

    loading  Loading Related Articles